Publications by authors named "Mark Alberts"

Claim this Profile
P
Prioritizing gaps in stroke care: A two-round Delphi process.
Elke Ge Mathijssen, Jaap Ca Trappenburg, Mark J Alberts, Angelique Balguid, Robert J Dempsey

Eur Stroke J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ischemic stroke prevention, apixaban and aspirin do not differ for intracranial hemorrhage events.
Mark J Alberts,

Ann Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA.
Mark J Alberts,

Ann Intern Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-pocket costs for direct oral anticoagulants and prescription abandonment among patients with nonvalvular atrial fibrillation or venous thromboembolism.
Maryia Zhdanava, Veronica Ashton, Jill Korsiak, Fengyi Jiang, Dominic Pilon, Mark Alberts

J Manag Care Spec Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity.
Mark Alberts, Jinghua He, Akshay Kharat, Christopher D Pericone, Veronica Ashton

J Am Heart Assoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In mild ischemic stroke or high-risk TIA, DAPT started ≤72 h after onset reduced new stroke and increased bleeding at 90 d.
Mark J Alberts

Ann Intern Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of State Stroke Center Certification and Designation Processes.
Madeline Feldmeier, Anthony S Kim, Kori S Zachrison, Mark J Alberts, Yu-Chu Shen

Stroke· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In ischemic stroke without large or medium vessel occlusion, tirofiban increased likelihood of an excellent outcome.
Mark J Alberts

Ann Intern Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy.
Mark J Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre

Curr Med Res Opin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study.
Mark Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre

Int J Clin Pharm· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
Mark J Alberts

Ann Intern Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Particle versus Liquid Embolic Materials Used in Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematoma.
Neeharika Krothapalli, Smit Patel, Mohamad Fayad, Ahmed Elmashad, Brendan Killory, Mark Alberts

World Neurosurg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation.
Mark Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study.
Mark Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre

Adv Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of reverse angle guide catheter with trans-radial approach in patients undergoing middle meningeal artery embolization.
Neeharika Krothapalli, Mohamad Fayad, Smit Patel, Ahmed Elmashad, Eric Sussman, Mark Alberts

Front Neurol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy.
Mark J Alberts, Jinghua He, Akshay Kharat, Veronica Ashton

Am J Cardiovasc Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Embolic Sources Differ in Patients With Embolic Stroke of Undetermined Source According to Age: A 15-Year Study.
Yan Hou, Ahmed Elmashad, Ilene Staff, Mark Alberts, Amre Nouh

Front Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation.
Dominick J Angiolillo, Jayne Prats, Efthymios N Deliargyris, David J Schneider, James Scheiman, Mark Alberts

Clin Pharmacokinet· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke: A Scientific Statement From the American Heart Association.
Amre Nouh, Sepideh Amin-Hanjani, Karen L Furie, Walter N Kernan, DaiWai M Olson, Mark J Alberts

Stroke· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis.
Smit D Patel, Karan Topiwala, Fadar Otite Oliver, Hamidreza Saber, Gregory Panza, Mark Alberts

Stroke· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin.
Dejan Milentijevic, Jennifer H Lin, Yen-Wen Chen, Emily Kogan, Shubham Shrivastava, Mark Alberts

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas.
Karan K Topiwala, Smit D Patel, Mubashir Pervez, Claire L Shovlin, Mark J Alberts

Stroke· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin.
Dejan Milentijevic, Jennifer H Lin, Nancy Connolly, Yen-Wen Chen, Emily Kogan, Mark J Alberts

J Stroke Cerebrovasc Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel GDF2 Gene Mutation Associated with Pulmonary Arteriovenous Malformation.
Karan K Topiwala, Smit D Patel, Amre M Nouh, Mark J Alberts

J Stroke Cerebrovasc Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database.
Benjamin Miao, Monique Miller, Belinda Lovelace, Anne Beaubrun, Kelly McNeil-Posey, Mark J Alberts

TH Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis